Renal carcinoma
MONDO:0005206A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis. The majority are renal cell carcinomas. Kidney carcinomas usually affect middle aged and elderly adults. Hematuria, abdominal pain, and a palpable mass are common symptoms.
Also known as: kidney (including renal cell) cancer, kidney (renal) cancer, kidney cancer, renal cancer, carcinoma of kidney, kidney carcinoma, renal carcinoma
3460 clinical trials for this condition and its sub-types, 85 tagged with Renal carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Renal carcinoma
-
Renal cell carcinoma 611 trials · 710 incl. sub-types
11 sub-types
- Renal cell adenocarcinoma 98 trials · 251 incl. sub-types Sub-types →
- Nonpapillary renal cell carcinoma 156 trials · 246 incl. sub-types Sub-types →
- Adrenal cortex carcinoma 42 trials Sub-types →
- Collecting duct carcinoma 18 trials
- Kidney medullary carcinoma 10 trials · 13 incl. sub-types Sub-types →
- MIT family translocation renal cell carcinoma 6 trials Sub-types →
- Wolffian duct adenocarcinoma 2 trials
- Acquired cystic disease-associated renal cell carcinoma 0 trials
- Cystic renal cell carcinoma 0 trials
- Mucinous tubular and spindle renal cell carcinoma 0 trials
- Renal pelvis adenocarcinoma 0 trials
-
Renal pelvis carcinoma 15 trials · 22 incl. sub-types
4 sub-types
- Renal pelvis urothelial carcinoma 16 trials Sub-types →
- Carcinoma in situ of renal pelvis 0 trials
- Renal pelvis adenocarcinoma 0 trials
- Renal pelvis squamous cell carcinoma 0 trials
-
Kidney carcinoma in situ 0 trials
1 sub-type
- Carcinoma in situ of renal pelvis 0 trials
Most studied deeper sub-types
-
Old drug, new hope: mercaptopurine tested against rare cancer syndrome
Disease control Not yet recruitingThis trial tests the drug mercaptopurine in people with hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a rare genetic condition that raises the risk of skin, uterine, and kidney tumors. The study aims to find the safest dose and see if the drug can shrink kidney canc…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New study tracks heat therapy for kidney tumors
Disease control Not yet recruitingThis study watches 226 adults with small kidney tumors (stage T1a) who get radiofrequency ablation, a treatment that uses heat to destroy cancer cells. Researchers will track how well the procedure works and any side effects. No extra treatments or tests are given—just normal car…
Sponsor: Humanitas Hospital, Italy • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Robot-Guided radiation aims to shrink kidney tumors with fewer side effects
Disease control Not yet recruitingThis study tests a highly precise type of radiation called SBRT for people with kidney cancer who cannot undergo surgery. The treatment uses a robotic system (CyberKnife) to deliver high-dose radiation directly to the tumor while sparing healthy tissue. Researchers will track 60 …
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Robot surgery showdown: single port vs multi port for cancer
Knowledge-focused Not yet recruitingThis study will compare two types of robot-assisted surgery for prostate or kidney cancer: single-port (one small incision) and multi-port (several incisions). Researchers will track 376 adults to see which approach leads to a shorter hospital stay and better recovery. The study …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC